Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia

A 50-year-old male with chronic lymphocytic leukemia (CLL) was treated with fludarabine, cyclophosphamide and rituximab, which produced a complete remission. Eight months after the last dose of rituximab he had visual disturbance, diminished muscular strength in the right arm and vesicular-papular l...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrote, Heidys, de la Fuente, Adolfo, Oña, Raquel, Rodríguez, Inmaculada, Echevarría, Juan E, Sepúlveda, Juan M, García, Juan F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357158/
https://www.ncbi.nlm.nih.gov/pubmed/25767742
http://dx.doi.org/10.1186/s40164-015-0003-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357158/
https://www.ncbi.nlm.nih.gov/pubmed/25767742
http://dx.doi.org/10.1186/s40164-015-0003-4

Ejemplares similares